Abstract
PROteolysis TArgeting Chimeras (PROTACs) are small molecules that induce target protein degradation via the ubiquitin-proteasome system. PROTACs recruit the target protein and E3 ligase; a critical first step is forming a ternary complex. However, while the formation a ternary complex is crucial, it may not always guarantee successful protein degradation. The dynamics of the PROTAC-induced degradation complex play a key role in ubiquitination and subsequent degradation. In this study, we computationally modelled protein complex structures and dynamics associated with a series of PROTACs featuring different linkers to investigate why these PROTACs, all of which formed ternary complexes with Cereblon (CRBN) E3 ligase and the target protein bromodomain-containing protein 4 (BRD4BD1), exhibited varying degrees of degradation potency. We constructed the degradation machinery complexes with Culling-Ring Ligase 4A (CRL4A) E3 ligase scaffolds. Through atomistic molecular dynamics simulations, we illustrated how PROTAC-dependent protein dynamics facilitate the arrangement of surface lysine residues of BRD4BD1 into the catalytic pocket of E2/ubiquitin for ubiquitination. Despite featuring identical warheads in this PROTAC series, the linkers were found to affect the residue- interaction networks, and thus governing the essential motions of the entire degradation machine for ubiquitination. These findings offer a dynamic perspective on ligand-induced protein degradation, providing insights to guide future PROTAC design endeavors.
Introduction
With the rapid progressive efforts from modern drug discovery and development, numerous promising paradigms for disease treatment are emerging from the wealth of medicinal chemistry and biology. A comprehensive understanding of the molecular mechanisms underlying the function of targeted biological systems expedites the drug development process. Among these innovative approaches, PROteolysis TArgeting Chimeras (PROTACs), also known as heterobifunctional degraders, stand out as a revolutionary paradigm for selectively degrading a diverse array of disease-associated targets1–3. The formation of a ternary complex involving a PROTAC binding to an E3 ligase and its neo-substrate, commonly referred to as the protein of interest (POI), triggers the cell’s native protein degradation machinery (e.g., ubiquitination), which marks the target protein for proteasomal degradation. Previous studies have highlighted the importance of forming a high binding-affinity, stable and long-lived E3-PROTAC-POI complex for achieving potent degradation4. However, it is noteworthy that the formation of a stable ternary complex does not always correlate with the degradation potency of the POI4–6.
The final degradation of the target protein, involving the three-step ubiquitination process (activation-E1, conjugation-E2, and ligation-E3) is facilitated by the binding a ternary complex induced by a PROTAC. Recent studies used E3 ligases such as MDM2, IAP, RNF4, and βTRCP to degrade various biological targets7–10. While stable ternary complexes are often associated with high POI degradation efficiency, discrepancy between stable ternary complexes and degradation have also been observed. For instance, certain von Hippel Lindau (VHL)-based PROTACs exhibit high binding affinity to POIs but fail to induce degradation despite forming stable ternary complexes. Conversely, proteins like p38α, which exhibit low binding affinity with VHL-based PROTACs, undergo rapid degradation within a short timeframe4,11,12. Therefore, it is evident that the formation of a stable ternary complex does not guarantee high degradation efficiency. Recent studies suggest that the accessibility of lysine (Lys) residues of the POI after the formation of stable ternary complexes is critical for degradation and requires further research4,13,14.
The formation of a stable E3-PROTAC-POI complex represents the initial crucial step for POI degradation. Several modeling-based approaches have been developed to optimize and rationalize the PROTAC-mediated ternary complex. For example, several studies have employed protein–protein docking, linker conformational searching15–18, and machine learning approaches19,20 to generate ensembles of E3-PROTAC-POI complexes in silico. Recent advancement in docking algorithms aim to provide higher accuracy and energetically favorable ternary complexes21,22. Notably, recent studies suggest that, in addition to forming a ternary complex, the orientations of E3-PROTAC-POI allowing accessibility of the surface Lys residues of the POI are important for ubiquitination. Because the subsequent ubiquitination process occurs in a ligase complex comprising multiple proteins, recent research efforts have begun to investigate the assembly of the E3-PROTAC-POI complex with the entire ligase complex and key enzymes E2/ubiquitin (E2/Ub) for ubiquitination. For example, two studies applied docking and structure-based modeling approaches to model CDKs-PROTACs and BCL-xl-PROTACs in a Cereblon (CRBN)-based Culling-Ring Ligase 4A (CRL4A) complex and a VHL-based CRL complex, respectively14,23. These studies integrate experimentally determined protein structures to construct a degradation complex using protein structure alignment approaches and the distance measurements between Lys residues to Ub were used to show potential ubiquitination Moreover, enhanced sampling molecular dynamics (MD) techniques have been employed to investigate the spatial organization of POI within the context of a ligase complex for ubiquitination24. Nevertheless, challenges remain in accurately modelling the functional dynamics of the degradation machinery complex and gaining a deeper understanding of the steps involved in POI ubiquitination to aid PROTAC design.
Several existing studies have examined a set of PROTACs targeting the same E3 ligase and POI for structure–activity relationships25–27. Many of these studies have maintained consistent binders for the E3 and POI while varying the linker regions. For example, studies of several PROTACs (i.e., small-molecule degrader of bromodomain and extra-terminal domain [dBET] family) designed for degrading bromodomain-containing protein 4 (BRD4BD1) utilized the same BRD inhibitor (i.e., thieno-triazolo-1,4-diazepine [JO1]) and E3 ligase inhibitor, pomalidomide (or lenalidomide and thalidomide) while varying the linkers6,28–30. Although the crystal structures of these CRBN-dBETs-BRD4BD1 ternary complexes have highly similar CRBN-BRD4BD1 contacts, significant differences in degradation capabilities (DC50/5h) have been observed6,28,31,32. These findings underscore the need to further understanding of how the linkers themselves and the formation of stable ternary complex may influence degradation capability. Although the linker region may result in minor differences in ligand solubility and/or membrane permeability, the proximity and accessibility of surface Lys residue(s) of the POI to the E2/Ub cascade in the ubiquitination site can be due to different linkers11,33. Thus, investigating the structures of the degradation complexes with PROTAC-induced ubiquitination while considering protein functional dynamics provide valuable insights into PROTAC degradability.
In this study, we employed protein–protein docking, structural alignment, atomistic MD simulations, and post-analysis to model a series of CRBN-dBET-BRD4BD1 ternary complexes and the entire degradation machinery complex consisting of BRD4BD1 and a CRL4A E3 ligase scaffold (Figure 1). These degraders, with different linker properties, were all capable of forming stable ternary complexes, but exhibited different degradation capabilities6,28,31,32. The best degrader, dBET70, had a DC50/5h of about 5 nM, followed by dBET23 (DC50/5h ∼50 nM) (Figure 1D and Figure S1). Although the protein–protein binding affinities were similar, other degraders such as dBET1 and dBET57 had a DC50/5h of about 500 nM. Our studies identified structural features of the dBETs that contribute to large-scale protein motions and explain the connection between the cellular activities and degradability reported for the dBETs. Because finding energetically stable ternary conformations is a critical first step for protein degradation6,17,18, in addition to protein–protein docking, we also performed MD simulations to thoroughly cover the conformation space and energy calculations to ensure that our modeled ternary complexes were thermodynamically stable.
Assembling these stable CRBN-dBETx-BRD4BD1 complexes into multiple modeled CRL4A E3 ligase-based scaffold conformations, we first observed that no surface Lys residue(s) of BRD4BD1 was ready for the next ubiquitination step in the modeled degradation machinery complexes. Nevertheless, our unbiased MD simulations illustrated protein functional dynamics of the entire complex and local side-chain arrangements to bring Lys residue(s) to the catalytic pocket of E2/Ub for reactions. Post-analysis revealed the essential motions of the degradation complex and interactions crucial for ubiquitination. Our results relate the functional motion to potential ubiquitination and explain how the linker property affects the degradation potency. Our shows the importance of the dynamic features in protein function and how the linker region of a PROTAC may contribute to protein motions to achieve PROTAC-mediated POI degradation.
Results
To understand why PROTACs, although forming similar stable E3-PROTAC-POI ternary complexes, induce different degradation efficacy of POIs, we used an integrative approach that combines docking, structural alignment and atomistic MD simulations (Scheme S1). Due to the limited availability of experimental determined CRBN-dBETx-BRD4BD1 conformations, we initially employed protein–protein docking to generate numerous CRBN-dBETx-BRD4BD1 ternary complexes for four degraders with different degradation efficacies (Table S1 and Figure S1). Subsequently, we constructed degradation machinery complexes by assembling various ternary complexes into the CRL4A E3 ligase scaffold. MD simulations and subsequent post- analysis were employed to quantify protein dynamics and identify crucial hinge regions governing the structure–dynamics–function relationship within the degradation complexes. With quantitative data, we revealed the mechanism underlying dBETx-induced degradation machinery.
Conformational ensembles of CRBN-dBETx-BRD4BD1 ternary complexes
An effective design of PROTACs relies on a comprehensive understanding how a degrader, such as dBET, yields different conformations of CRBN-dBETx-BRD4BD1 ternary complexes, ultimately contributing to degradation efficiency. To generate the conformation ensemble, we first constructed the ternary complexes through protein–protein docking using the Molecular Operating Environment (MOE) program, ensuring the removal of complexes with atomic clashes (refer to SI for docking data). Figure S1 illustrates the docked CRBN-dBETx-BRD4BD1 conformations, with all conformations, except CRBN-dBET57-BRD4BD1, presenting over 160 conformations and displaying various inter-molecular orientations between CRBN and BRD4BD1. Notably, PROTAC dBET57, characterized by a shortest linker, exhibited a constrained protein– protein orientation, resulting in only 24 distinct ternary conformations (Figure S1C and Table S1). To validate the modelled conformations, we superimposed the docking results of CRBN- dBET23-BRD4BD1 and CRBN-dBET70-BRD4BD1 ternary complexes onto available crystal structures, revealing highly similar conformations. The computed smallest Ca-root mean square deviation (RMSD) values were 1.99 Å, and 2.60 Å, respectively (Figure S2). These ternary ensembles, as depicted in Figure S1, were subsequently utilized to construct degradation machinery complexes, as detailed in the following subsection.
Furthermore, we conducted multiple MD simulations in explicit solvent for five CRBN-dBETx- BRD4BD1 complexes, encompassing four initial conformations derived from our docking model and one from an existing crystal structure (Table 2, total of 15 runs for ternary complexes). During 400-ns simulations, the two warheads of a PROTAC bound tightly to CRBN and BRD4BD1, while the linker displayed high flexibility adopting different conformations and facilitating the interaction between the two proteins across different protein–protein contact surfaces (Figure 2). Interestingly, despite our molecular docking results suggesting limited fluctuation in CRBN-dBET57-BRD4BD1, our MD simulations revealed considerable variation in ternary conformations. The observed large-scale motions in all CRBN-dBETx-BRD4BD1 complexes, as predicted by both docking and MD simulations, underscored the importance of CRBN and BRD4BD1 orientations influenced by the presence of dBETs as key factors of contributing to degradation efficiency.
Modelled degradation machinery complexes
To facilitate ubiquitination, once a stable CRBN-dBETx-BRD4BD1 complex is formed, led by CRBN, the ternary complex is assembled with an E3 ligase scaffold for ubiquitination. For this purpose, we utilized a widely employed scaffold, CRBN/DDB1/CUL4A/NEDD8/Rbx1/E2/Ub, to assemble our ternary complex, with CRBN binding to the adaptor protein DDB1 to bring the target protein into proximity with E2/Ub (Figure 1B). Given the dynamic nature of the scaffold complex, we selected 12 distinct DDB1 crystal structures to construct multiple scaffold conformations18. Notably, among these structures, only one of the 12 PDB files had CRBN bound to DDBI (PDB ID 4TZ4). Using this crystal structure as a template, we further built 12 CRL4A E3 ligase scaffolds: DDB1/CUL4A/NEDD8/Rbx1/E2/Ub/CRBN. Subsequently, three of the resulting 12 complexes were found to contain clashes and were excluded from further analysis (Figure S4). The remaining nine CRL4A E3 ligase scaffolds all formed a ring-like overall shape. We further analyzed the conformations and clustered them using a distance between the E2 and CRBN interface revealed two distinct groups: the ring-forming cluster A, characterized by a gap distance ranging from ∼1.0 Å to 10.0 Å (Figure S5A, clusters A1-5), and the ring-open cluster B, featuring a much larger gap distance ranging from ∼14 Å to 35 Å (Figure S5B, clusters B1-4). Subsequently, we allocated 561 modeled CRBN-dBETx-BRD4BD1 conformations, along with a crystal structure (CRBN-dBET23-BRD4BD1), into the nine CRL4A E3 ligase scaffolds, labeled A1 to A5 and B1 to B4, resulting in the construction a total of 5058 degradation machinery complexes.
According to mechanistic studies23,34, both a Lys residue of the POI and the Gly in the C- terminal G-G motif in Ub must be positioned within an Asp-rich catalytic site for the ubiquitination reaction to occur, with Ub conjugated to the POI by forming a covalent bond between Lys and Gly (Figure 1C). Using the distance between one Lys of BRD4BD1 and the C- terminal Gly of Ub as a criterion, we examined each Lys of BRD4BD1 across the 5058 degradation machinery complexes. Any complex in which the distance between any Lys of BRD4BD1 and the C-terminal Gly of Ub was found to be < 16 Å was retained, resulting in the identification of 1226 degradation machinery complexes with diverse conformations (Table 1). For instance, within cluster B1 scaffold, dBET23 yielded 104 conformational degradation complexes (Figure S6). It is noteworthy that in each degradation machinery complex, at least one Lys residue was found within the cutoff criterion. However, due to the wide ring-open conformations of clusters B3 and B4, none of the modelled degradation complexes utilizing these two clusters satisfied our criterion. Given that a distance of 16 Å may appear to be relatively large for catalysis14, so we postulated that protein dynamics could potentially bring the relevant residues into close proximity to facilitate the ubiquitination reaction.
Among the docked ensembles of each CRBN-dBETx-BRD4BD1, all top-ranked ternary complexes from protein–protein docking were successfully integrated with the scaffold clusters A and B without encountering clashes (Figure S7). For example, dBET1_#35 and dBET70_#91 exhibited the most favorable protein–protein docking energies (Table S2). Intuitively, one might prioritize the ring-forming cluster A due to its smaller gap between the E2 and CRBN interface, potentially facilitating the proximity of Lys and Gly for ubiquitination. However, the conformational ensemble of each CRBN-dBETx- BRD4BD1 provided numerous possible orientations for assembly within the degradation complex, regardless of whether the CRL4A E3 ligase scaffold adopts a ring-forming or ring-open conformation.
Moreover, when constructing a degradation complex, all the highest-ranked ternary complexes from docking scores displayed similar conformations for dBETs, implying that the preferred PROTAC conformations may be predicted. These popular ternary complexes exhibited similar protein–protein contacts and linker conformations (Figure S8). Our MD simulations further demonstrated that these initial structures used for modeling degradation complexes effectively directed BRD4BD1 toward ubiquitination (see next subsection).
Protein functional dynamics in degradation machinery complex
Among the 1226 distinct degradation machinery complexes constructed, none showed the structure of a Lys residue of BRD4BD1 was positioned for ubiquitination. Therefore, for each PROTAC, we selected a degradation machinery complex conformation in clusters A and B with a top docking score CRBN-dBETx-BRD4BD1 ternary conformation for MD simulations (Table 2). To further evaluate the docking scores, we also performed protein–protein interaction energy calculations using MD runs initiated by these ternary conformations with top docking scores. The energy calculations confirmed the thermodynamic stability of top-ranked ternary complexes obtained through protein–protein docking, highlighting the robust binding of their associated dBETs (Figure S9). Moreover, they remained stable throughout the MD runs, as evidenced by RMSD plots (see RMSD plots in Figure S10).
After confirming that each CRBN-dBETx-BRD4BD1 used for constructing the degradation complexes represented popular ternary conformations, we conducted classical MD simulations for these degradation complexes to observe functional dynamics and local interactions that lead to successful ubiquitination. Notably, to ensure that the compatibility of each CRBN-dBETx- BRD4BD1 with both clusters A and B of CRL4A E3 ligase scaffolds, we also selected a few ternary complexes from our MD runs (Table 2). As depicted in Figure 1C, a successful ubiquitination reaction requires protein conformational arrangements that bring a surface Lys of BRD4BD1 close to Gly of Ub, where at least one Asp of E2 positioned in proximity to the same Gly to facilitate charge transfer. Therefore, we employted two criteria: (1) ensuring that the distance between Lys (N atom) and Gly (C atom) was less than 10 Å; and (2) confirming that distance between Asp (O atom) of E2 and the same Gly (O atom) was less than 6 Å to determine the likelihood of ubiquitination.
Although none of the initially modelled machinery complexes exhibited a Lys residue of BRD4BD1 being ready for ubiquitination, our MD sampling facilitated the movement of different Lys residues of BRD4BD1 from distance greater than 16 Å of the catalytic pocket on E2 to establish close contacts with Gly of Ub for each dBET. Specifically, we observed significant large-scale motions within degradation complex B1_dBET1_#35 (cluster B, docked conformation #35), which recruited three Lys residues K72, K76 and K111 at distances greater than 16 Å, positioning them in the catalytic pocket on E2. Concurrently, a conserved charged residue Asp of E2 approached the C-terminus G75 of Ub, potentially facilitating isopeptide bond formation (Figures 3A and B). Similarly, degradation complex B1_dBET23_#14 (cluster B, docked conformation #14) and B1_dBET70_#91 (cluster B, docked conformation #91) also brought K99 of BRD4BD1 into proximity of the catalytic cavity of E2, where one Asp of E2 approached the the C-terminus G75 of Ub as well (Figure 3C, D, G and H). In contrast, degradation complex B1_dBET57_#9MD1 (cluster B, conformation from MD run 1 initiated with docked conformation #9) positioned K102 of BRD4BD1 in close proximity to the catalytic pocket on E2 (Figures 3E and 3F). Notably, BRD4BD1 of dBET1, dBET23 and dBET70 exhibited a closer proximity to Ub (∼6 Å) as compared to dBET57 (∼10 Å) (Figure 3A, C, E, and G). Despite degradation complex B1_dBET1_#35 positioned three Lys residues of BRD4BD1 to form stable interactions with the Gly of Ub, the surrounding Asp of E2 was unstable which hindered a successful ubiquitination process (Figure 3A and S11). Further analysis revealed that dBET23 (∼85%) and dBET70 (∼78%) exhibited a higher probability of fulfilling both criteria for potential chemical reactions, whereas dBET1 (∼40%) and dBET57 (∼22%) had a lower likelihood (Figure S11D). This analysis revealed how dBET23 and dBET70 achieved high degradation efficiency, while dBET1 and dBET57 induced protein motions for bond formation, without achieving all required arrangements simultaneously, resulting in lower degradation efficiency. Our findings are consistent with experimental measurements indicating that all dBETs could degrade BRD4BD1 but with varying degradation potency. By considering the Lys–Gly and Asp-Gly distances, our simulations underscored that dBET23 and dBET70 (with DC50/5h values of ∼5 nM and ∼50 nM, respectively) are more efficient degraders compared to dBET1 and dBET57 (with DC50/5h values of ∼500 nM).
To gain further insights into the overall motion of the degradation complexes, we employed principal component analysis (PCA) to extract essential motions within the complex; Notably, the first two PC modes, PC1 and PC2, accounted over 60% of the overall motions in most MD runs (Table S4). While the specific nature of these motions varied depending on the system, the dBETs induced an inter-protein orientation between CRBN and BRD4BD1, with two hinge regions: loops in Rbx1 and DDB1 proteins contributing prominently to the essential motions of the complex (Figure S12). These two hinge regions exhibited twisted and opposite direction motions, facilitating the rearrangement and bringing BRD4BD1 closer to the catalytic cavity of E2, which is a critical step for successful ubiquitination. Indeed, the essential motions revealed by the first two PC modes clearly revealed the plasticity between the protein–protein interfaces in the degradation machinery. Notably, the most significant motion in PC1 shifted E2/Ub/Rbx1/NEDD8 closer to BRD4BD1 (Figure S13). Furthermore, the pairwise force matrix between individual residues within the degradation complex offered insights into the non-covalent interactions governing the dynamic behavior of the complex. This interaction network, starting from the dBETs’ linker and extending to the hinge loop of DDB1 and Rbx1 (Figure S14), indicated a clear correlation between linker rotation and the movement of the entire degradation complex. Our study highlights the importance of functional dynamics of the degradation complex during the ubiquitination processes, which is influenced by a dBET ligand.
To quantify the correlation between linker rotation and the movement of the degradation complex, we selected four atoms shown in Figure 4A to construct a pseudo dihedral angle and used histograms to depict the population of these pseudo angles. Deviations between the histograms from different time periods indicated the motion of the degradation complex during the MD simulations. Across the first and last 100 ns of an MD run, the degradation complexes large motions with the presence of each dBET (Figure 4B). Given that the only distinction among the four dBETs was the linker, we observed that the complex motions correlated to the C- C-N3-C dihedral angles in the linkers of dBET1, dBET23, dBET70, and dBET57 (Figure 5A). Notably, all four dBETs exhibited substantial shifts of BRD4BD1 of approximately 10 and 15 degrees, which underscores their flexibility in promoting extensive motion of the BRD4BD1 protein for Lys–Gly interaction. The various motions from different degradation complexes also resulted in different sets of Lys residues potentially forming contacts with E2 and Ub. For instance, the degradation complexes dBET23_#14 and dBET70_#91 brought K99 of BRD4BD1 closer to G75 of Ub (Figure 5B), while dBET57_#9MD1 placed K102 in proximity to G75 of Ub. Despite allowing for different Lys–Gly interactions, dBET57 exhibited weaker interactions. The pairwise force analysis revealed a strong attraction between K99 and G75 of dBET23 and dBET70, and a weaker attraction between K102 and G75 of dBET57_#9MD1 (Figure S15).
Given the presence of numerous local energy minima conformations in the degradation complex, MD simulations could not sample all conformations comprehensively. Furthermore, as evidenced by the protein–protein docking results (Figure S1C), the short linker of dBET57 yielded a less flexible ternary complex, suggesting challenges in sampling various conformations using MD runs. To address this, we selected another distinctly different ternary complex of dBET57 (Figure S16B) to construct another degradation complex, B1_dBET57#9_MD2, for MD simulation. Unlike B1_dBET57#9_MD1, B1_dBET57_#9_MD2 exhibited significantly more rigidity, with only minimal rotation (< 5 degrees) in the pseudo dihedral angle. Thise rigidity limits the functional dynamics to bring BRD4BD1 close to Ub for Lys–Gly interactions (Figure S16). This observation underscores the crucial role of the linker in guiding the motion of the degradation complex, thereby influencing its capacity for ubiquitination. In summary, the linker induces conformations of ternary complexes but also guides the motion of the degradation complex, which allows an effective Lys–Gly interaction for ubiquitination. Our studies highlight the critical role of linker flexibility in facilitating protein functional dynamics necessary for ubiquitination.
Discussion
As bifunctional small-molecule ligands, PROTACs play a pivotal role in recruiting a neo- substrate of E3 ligase, namely the target protein POI, to form a ternary E3-PROTAC-POI complex by stabilizing the protein–protein interactions. By forming an E3-PROTAC-POI complex, E3 ligase brings the POI close to an E2 enzyme for protein ubiquitination, with both E2 and E3 proteins belonging to a larger Ub ligase machinery complex. While forming a stable E3- PROTAC-POI complex represents a critical step in ubiquitination, it alone is insufficient for subsequent ubiquitination and degradation by proteasomes. Several studies suggest that positioning the POI’s Lys residues close to the E2 for ubiquitination is crucial for successful POI degradation11,24,35. However, due to the lack of experimental determined structures for POI- bound degradation complexes, directly observing the proximity of Ub to POI’s Lys residues remains challenging. In addition, proteins exhibit dynamic behaviors, and the fluctuation in the ternary E3-PROTAC-POI complex and the degradation machine can either promote or impede catalytic activity. To investigate the degradability of PROTACs, we employed a strategy combining protein docking, MD simulations, and structural and energy analysis tools. Our focus was on a series of dBET degraders, differing in their linkers, which all induced stable CRBN- dBETx-BRD4BD1 complexes different degradation efficiencies.
One straightforward approach to promote ubiquitination is to obtain a stable E3-PROTAC-POI ternary complex to allow pre-organized orientation placing a Lys residue(s) of the POI close to the E2/Ub catalytic site in the degradation machine. However, experimental determined structures for degradation complexes are scarce. Protein–protein docking can reveal low energy ternary complexes and popular conformational ensembles, providing insights into potential orientations for ubiquitination. observe whether the preferred conformations are pre-organized for ubiquitination. Although protein–protein docking is usually quick (i.e., <50 hr to sample 5000 protein–protein complexes using one CPU in computation), the docked E3-PROTAC-POI conformations may not be the functionally active form to induce successful ubiquitination.
Nevertheless, results from protein–protein docking are highly informative and suggest potential flexibility of a ternary complex, as shown in Figure S1. However, MD simulations or other conformational search methods can further generate more stable ternary conformations, and the sampling from protein–protein docking may not be thorough. As illustrated by dBET57, protein– protein docking generated only similar ternary complex conformations (Figure S1C). In contrast, classical MD simulations using all atoms and explicit water molecules sampled additional low energy conformations (Figure 3C).
Using the protein–protein docking results, multiple thermodynamically stable ternary E3- PROTAC-POI conformations were placed in the degradation machine to access whether surface Lys residues of POI were appropriately orientated for ubiquitination. However, relying solely on a handful of static conformations for predicting POI degradability is not insufficient. For example, our docking results showed that none of the Lys residues of BRD4BD1 was ready for ubiquitination. Notably, our modelled CRL4A E3 ligase scaffolds in Figure S5 show two distinct conformations: a ring-forming conformation (cluster A) with a gap distance approximately 1.0 Å to 10.0 Å, and a ring-open conformation (cluster B) with a much larger gap distance, approximately 14 Å to 35 Å. When docking the ternary complex into the ring-forming scaffold (Figure S5A), the orientations of BRD4BD1 tended to be sterically confined, limiting their range of motion to bring one Lys residue of BRD4BD1 closer to the Gly of Ub. In contrast, using MD to simulate protein dynamics, CRL4A E3 ligase scaffolds with ring-open conformations provided a larger space that may allow an assembled BRD4BD1 to properly rearrange its conformations for successful ubiquitination, even though the initial distance between BRD4BD1 and Ub is far. Our studies demonstrated that using CRBN-dBETs-BRD4BD1 conformations sampled by protein–protein docking and/or MD simulations provided reasonably good initial structures to model the functional dynamics of the degradation machinery. The essential motions were captured by PCA, which illustrated that all dBETs studied can produce motions to bring BRD4BD1 closer to Ub, thus supporting their degradability. Atomistic simulations revealed that specific Lys residue(s) of BRD4BD1 (i.e., K99, K102 and K72/76/111 of dBET23 and dBET70, dBET57 and dBET1, respectively) were attracted by polar residues around Ub and E2.
The analysis of how a PROTAC, particularly the linker region, affects the overall dynamics and specific arrangements to bring Lys close to the catalytic site offers further information on linker design. The slight variations in linker length and composition that may significantly alter the degradability of a PROTAC was puzzling. Even though PROTACs can strengthen interactions between E3 and POI, protein degradation is not always associated with forming stable ternary complexes. One hypothesis is that some ternary complexes have a preferred E3/POI orientation in the degradation machinery complex to result in efficient ubiquitination. Here we demonstrated that by using accurately modeled initial conformations, performing a few hundred nanosecond classical MD simulations could illustrate how protein functional dynamics orient surface Lys residues of BRD4BD1 and Asp of E2 close to the Gly of Ub, thus offering information for predicting protein degradation. We examined the hinges and used pseudo-dihedral angles of the degradation complexes to describe the large-scale swinging motions near the end of the MD runs (300-400 ns). To understand the role of the linker of different dBETs, we compared conformation ensembles from the first and last 100 ns of MD simulations. The movement of the degradation machinery correlated with rotations of specific dihedrals of the linker region in dBETs (Figure 5). This phenomenon shows that dBETs contribute to the functional dynamics of degradation complexes and suggests that linkers with different properties may lead to various large-scale motions.
The dynamics of the degradation machinery, induced by PROTACs, has implications in linker design and degradation prediction. Because the “warhead” (thieno-triazolo-1,4-diazepine [JQ1]) used to bind to an E3 ligase and the “warhead” (pomalidomide) used to bind to a POI are tightly bound ligands to each protein, the two warheads typically have limited motions when they are in the binding site of E3 or POI. Clearly, the length and composition of the linker are critical in degradation efficiency, and sites of conjugation to each warhead also affect the stability of the ternary complexes. Despite no general rules that apply to every system for PROTAC linker design, guidelines used in designing small-molecule drugs binding to their target proteins still hold. First, the linker should have sufficient length to form a ternary complex. Although longer and more flexible linkers typically provide enhanced opportunities for E3-PROTAC-POI complexes to orient suitable conformations for ubiquitination, shorter and/or rigid linkers may provide a preorganized E3-PROTAC-POI for efficient catalysis. However, knowing in advance the best related orientations is challenging, but the shorter linker in our systems, dBET57, had disadvantages in accommodating a Lys residue in the E2/Ub catalytic region for forming stable interactions for catalysis. In contrast, dBET23 and dBET70, with greater flexibility, allowed BRD4BD1 to adopt diverse conformations for catalysis, ultimately leading to more efficient degradation. Notably, although dBET1 recruited multiple Lys residues in the E2/Ub catalytic region and K111 was highly stable. The unstable Asp from the surrounding prevented charge transfer, and thus hindered the isopeptide bond formation for degradation. Notably, dBET1 and dBET57 still induce stable CRBN-dBET57-BRD4BD1 and CRBN-dBET1-BRD4BD1 complexes, which effectively assemble the neo-substrate BRD4BD1 with the degradation machine. However, the either Lys–Gly or Asp-Gly attractive force was unstable, which reduced the chances for successful ubiquitination.
Revealing functional dynamics of the entire degradation complex that bring surface Lys residue(s) of BRD4BD1 for target ubiquitination explains the degradability of these dBETs. Notably, the classical MD trajectories with atomistic details offer information about overall protein motions and specific Lys residues critical for the degradability of BRD4BD1 for further investigation. Theoretically speaking, excessively long MD simulations should be able to sample a wide range of protein conformations. However, long MD simulations can still stick in local minima and are computationally expensive. We demonstrated the use of the most stable ternary CRBN-dBETx-BRD4BD1 conformations from protein–protein docking to facilitate sampling the correct orientation of the surface Lys residue(s) of BRD4BD1 for ubiquitination. Of note, CRBN- dBET57-BRD4BD1 formed by the more rigid linker of dBET57 could be more easily trapped in a local energy minimum, and we need to select conformations from both protein-docking (dBET57_#9) and MD-sampling results (CRBN-dBET57#9-BRD4BD1) to construct the degradation machinery complex for functional dynamics studies. Different E3 ligases may also result in significantly different related orientation when bound to the same POI. Although static conformations from experimentally determined structures may suggest whether a dBET orients CRBN-dBETx-BRD4BD1 conformations suitable for degradation, real motions cannot be predicted directly from static conformations. Examining the dynamic nature of the degradation complex provides a more complete picture of the conformations of both ternary CRBN-dBETx-BRD4BD1 and machinery complexes that determine Lys accessibility for POI ubiquitination, an important factor for consideration when optimizing a PROTAC to improve its potency.
Synopsis
Our study showcased mechanistic insights with atomistic details into PROTAC-induced protein functional dynamics within degradation machinery complex with multi-level modeling approaches.
Acknowledgements
We thank Drs. Eric Fischer and Radosław Nowak for helpful discussions and for providing experimental data for protein binding and degradation efficiency, and Dr. Kevin Kou for helpful discussions regarding the mechanisms of isopeptide bond formation. This publication was made possible by Grant No. GM109045 and GM151651 from the National Institute of General Medical Sciences (NIGMS) of the NIH.
References
- (1)Advancing Targeted Protein Degradation for Cancer TherapyNat Rev Cancer 21:638–654
- (2)PROTAC Targeted Protein Degraders: The Past Is PrologueNat Rev Drug Discov 21:181–200
- (3)Building Ubiquitination Machineries: E3 Ligase Multi-Subunit Assembly and Substrate Targeting by PROTACs and Molecular GluesCurr Opin Struct Biol 67:110–119https://doi.org/10.1016/j.sbi.2020.10.009
- (4)Lessons in PROTAC Design from Selective Degradation with a Promiscuous WarheadCell Chem Biol 25:78–87
- (5)A Chemoproteomic Approach to Query the Degradable Kinome Using a Multi-Kinase DegraderCell Chem Biol 25:88–99
- (6)Plasticity in Binding Confers Selectivity in Ligand-Induced Protein DegradationNat Chem Biol 14:706–714https://doi.org/10.1038/s41589-018-0055-y
- (7)Induction of Apoptosis in MDA-MB-231 Breast Cancer Cells by a PARP1-Targeting PROTAC Small MoleculeChemical Communications 55:369–372https://doi.org/10.1039/C8CC07813K
- (8)PROTAC-Mediated Degradation of Bruton’s Tyrosine Kinase Is Inhibited by Covalent BindingACS Chem Biol 14:342–347https://doi.org/10.1021/acschembio.8b01094
- (9)Covalent Ligand Screening Uncovers a RNF4 E3 Ligase Recruiter for Targeted Protein Degradation ApplicationsACS Chem Biol 14:2430–2440https://doi.org/10.1021/acschembio.8b01083
- (10)Assessing Different E3 Ligases for Small Molecule Induced Protein Ubiquitination and DegradationACS Chem Biol 12:2570–2578https://doi.org/10.1021/acschembio.7b00485
- (11)Differential PROTAC Substrate Specificity Dictated by Orientation of Recruited E3 LigaseNat Commun 10:1–13
- (12)Modular PROTAC Design for the Degradation of Oncogenic BCR-ABLAngewandte Chemie International Edition 55:807–810https://doi.org/10.1002/anie.201507634
- (13)A Suite of Mathematical Solutions to Describe Ternary Complex Formation and Their Application to Targeted Protein Degradation by Heterobifunctional LigandsJournal of Biological Chemistry 295:15280–15291https://doi.org/10.1074/jbc.RA120.014715
- (14)Modeling the CRL4A Ligase Complex to Predict Target Protein Ubiquitination Induced by Cereblon-Recruiting PROTACsJournal of Biological Chemistry 101653
- (15)In Silico Modeling of PROTAC-Mediated Ternary Complexes: Validation and ApplicationJ Chem Inf Model 59:1634–1644
- (16)Improved Accuracy for Modeling PROTAC-Mediated Ternary Complex Formation and Targeted Protein Degradation via New in Silico MethodologiesJ Chem Inf Model 60:5234–5254
- (17)PRosettaC: Rosetta Based Modeling of PROTAC Mediated Ternary ComplexesJ Chem Inf Model 60:4894–4903
- (18)Rationalizing PROTAC-Mediated Ternary Complex Formation Using RosettaJ Chem Inf Model 61:1368–1382https://doi.org/10.1021/acs.jcim.0c01451
- (19)Bayesian Optimization for Ternary Complex Prediction (BOTCP)Artificial Intelligence in the Life Sciences 3https://doi.org/10.1016/j.ailsci.2023.100072
- (20)Accelerated Rational PROTAC Design via Deep Learning and Molecular SimulationsNat Mach Intell 4:739–748
- (21)High Accuracy Prediction of PROTAC Complex StructuresJ Am Chem Soc 145:7123–7135https://doi.org/10.1021/jacs.2c09387
- (22)Rational Prediction of PROTAC-Compatible Protein–Protein Interfaces by Molecular DockingJ Chem Inf Model https://doi.org/10.1021/acs.jcim.3c01154
- (23)Development of a BCL-XL and BCL-2 Dual Degrader with Improved Anti-Leukemic ActivityNat Commun 12:1–14
- (24)Predicting the Structural Basis of Targeted Protein Degradation by Integrating Molecular Dynamics Simulations with Structural Mass SpectrometryNat Commun 13https://doi.org/10.1038/s41467-022-33575-4
- (25)An Overview of PROTACs: A Promising Drug Discovery ParadigmMolecular Biomedicine 3https://doi.org/10.1186/s43556-022-00112-0
- (26)E3 Ligase Ligands in Successful PROTACs: An Overview of Syntheses and Linker Attachment PointsFront Chem 9https://doi.org/10.3389/fchem.2021.707317
- (27)Discovery of E3 Ligase Ligands for Target Protein DegradationMolecules 27https://doi.org/10.3390/molecules27196515
- (28)Discovery of a Small-Molecule Degrader of Bromodomain and Extra-Terminal (BET) Proteins with Picomolar Cellular Potencies and Capable of Achieving Tumor RegressionJ Med Chem 61:462–481
- (29)Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4Chem Biol 22:755–763
- (30)Selective Inhibition of BET BromodomainsNature 468:1067–1073
- (31)Phthalimide Conjugation as a Strategy for in Vivo Target Protein DegradationScience 348:1376–1381
- (32)Discovery of QCA570 as an Exceptionally Potent and Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of the Bromodomain and Extra-Terminal (BET) Proteins Capable of Inducing Complete and Durable Tumor RegressionJ Med Chem 61:6685–6704
- (33)Machine Learning Modeling of Protein-Intrinsic Features Predicts Tractability of Targeted Protein DegradationGenomics Proteomics Bioinformatics
- (34)E2 Superfamily of Ubiquitin-Conjugating Enzymes: Constitutively Active or Activated through Phosphorylation in the Catalytic CleftSci Rep 5:1–13
- (35)Structural Basis of Lenalidomide-Induced CK1α Degradation by the CRL4CRBN Ubiquitin LigaseNature 532:127–130
Article and author information
Author information
Version history
- Preprint posted:
- Sent for peer review:
- Reviewed Preprint version 1:
Copyright
© 2024, Wu et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
- views
- 356
- downloads
- 17
- citations
- 0
Views, downloads and citations are aggregated across all versions of this paper published by eLife.